疾病活动较低的原发性Sjögren综合征患者疾病进展的危险因素:基于多中心注册的队列研究
Xiangpeng Wang1,2,3,4, Shihao He1,2,3,4, Xiao Liang1,2,3,4
1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China.
Clinical rheumatology
|January 21, 2026
概括
几乎三分之一的初级Sjögren患者.
科学领域:
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
- 临床研究 临床研究
背景情况:
- 主要Sjögren综合征 (pSS) 患者的疾病活性较低,仍有进展的风险.
- 在低活性PSS中疾病恶化的预测因素尚不清楚.
研究的目的:
- 为了确定疾病恶化的风险因素,在初级的Sjögren综合征患者呈现最初低的疾病活动.
主要方法:
- 一项基于注册表的队列研究利用了从中国风湿病数据中心 (CRDC) 收集的前性数据.
- 包括符合分类标准的pSS患者,基线ESSDAI<5.
- 使用LASSO选择的Cox比例危险回归确定了疾病恶化的独立风险因素 (定义为ESSDAI增加≥3).
主要成果:
- 在745名患者中,28.7%的患者在36个月的中位随访期间经历了疾病恶化.
- 确定的独立风险因素包括脏干扰 (HR=6.18),抗Sm抗体阳性 (HR=2.10) 和干眼症状 (HR=1.46).
结论:
- 在pSS中疾病活性较低并不能确保疾病的稳定性,近三分之一的疾病进展.
- 脏干扰,抗Sm抗体和干眼症状是低活性PSS进展的关键预测因素.
- 使用这些因素的风险分层可以指导对高风险患者进行更密切的监测和治疗决策.
更多相关视频
相关概念视频
Factors Affecting Illness
5.4K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.4K
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
773
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Nephrotic Syndrome II : Assessment and Medical Management
422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422
Myasthenia Gravis ll: Pathophysiology
69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69


